Statistical Methodology
22.Li X., Miao W., Lu F., Zhou XH. Improving efficiency of inference in clinical trials with external control data. Biometrics. 2021;1-10. DOI: 10.1111/biom.13583
23.Zhou J., Zhou XH., Sun L. Comparison of Two Frameworks for Analyzing Longitudinal Data. Statistical Science 2021; 36:4, 530–541
24.Qiu Y., Tao J., Zhou XH. Inference of Heterogeneous Treatment Effects Using Observational Data with High-Dimensional Covariates. Journal of the Royal Statistical Society Series B. 2021; 83:1016-1043.
25.Miao M., Meng F., Liu Y., Zhou XH., Zhou J. 2021. Prevent the Language Model from being Overconfident in Neural Machine Translation. In Proceedings of the 59th Annual Meeting of the Association for Computational Linguistics and the 11th International Joint Conference on Natural Language Processing (Volume 1: Long Papers), pages 3456–3468, Online. Association for Computational Linguistics.
26.Deng Y., You C., Liu Y., Qin J., Zhou XH. Estimation of incubation period and generation time based on observed length-biased epidemic cohort with censoring for COVID-19 outbreak in China. Biometrics. 2021; 77:929–941. https://doi.org/10.1111/biom.13325
27.Hattori S., Zhou XH. Summary concordance index for meta-analysis of prognosis studies with a survival outcome. Statistics in Medicine. 2021; 40:5218–5236.
28.Deng Y., Chen F., Li Y., Qian K., Wang R., Zhou XH. A powerful test for the maximum treatment effect in through QT/QTc studies. Statistics in Medicine. 2021; 40:1947–1959.
29.Deng Y., Zhou XH. Caution About Truncation-By-Death in Clinical Trial Statistical Analysis: A Lesson from Remdesivir[J]. China CDC Weekly, 2021,3(25):538-540.
30.Qiu Y., Zhou XH. Inference on Multi-level Partial Correlations Based on Multi-subject Time Series Data. Journal of the American Statistical Association 2021, 00:0, 1-15. DOI: 10.1080/01621459.2021.1917417
31.Han S., Cai J., Yang J., Zhang J, Wu Q., Zheng W., Shi H., Ajelli M., Zhou XH., Yu H. Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity. Nature Communications. 2021, 12(1): 1-10.
32.Li W., Geng Z., Zhou XH. Causal mediation analysis with sure outcomes of random events model. Statistics in Medicine, 2021.
33.Guo W., Zhou XH., Ma S. Estimation of Optimal Individualized Treatment Rules Using a Covariate-Specific Treatment Effect Curve with High-Dimensional Covariates. Journal of American Statistical Association 2021, 116:533, 309-321.
Medical
34.You C., Gai X., Zhang Y., Zhou XH. Determining the Covertness of COVID-19— Wuhan, China, 2020. China CDC Weekly, 2021.
35.Zhou F., You C., Zhang X., Qian K., Hou Y., Gao Y., Zhou, XH. Epidemiological characteristics and factors associated with critical time intervals of COVID-19 in eighteen provinces, China: A retrospective study. International Journal of Infectious Diseases. 2021; DOI: 10.1016/j.ijid.2020.09.1487
36.Zhang, Y., You C., Gai X., Zhou XH. On Coexistence with COVID-19: Estimations and Perspectives，China CDC Weekly 2021(12)50
37.Yang B., Zhang Z., Chen X., Wang X., Qin S., Du L., Yang C., Zhu L., Sun W., Zhu Y., Zheng Q., Zhao S., Wang Q., Zhao L., Lin Y., Huang J., Wu F., Lu L., Wang F., Zheng W., Zhou XH., Zhao X., Wang Z., Sun X., Ye Y., Wang S., Li Z., Qi H., Zhang Z., Kuang D., Zhang L., Shen Z., Liu W. An Asian-specific variant in human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment. Journal of Clinical Investigation. 2021
38.Guo L., Yi X., Chen L., Zhang T., Guo H., Chen Y., Cheng J., Cao Q., Liu H., Hou C., Qi L., Zhu Z., Liu Y., Kong R., Zhang C., Zhou XH, Zhang Z, Song T, Xue R., Zhang N. Single cell DNA sequencing reveals punctuated and gradual clonal evolution in hepatocellular carcinoma. Gastroenterology,2021. doi: https://doi.org/10.1053/j.gastro.2021.08.052
